<?xml version="1.0" encoding="utf-8"?><api:response xmlns:api="http://www.symplectic.co.uk/publications/api"><api:version uri="https://mypublications.shef.ac.uk/" elements-version="6.15.0.3976" schema-version="6.13" product-name="myPublications"/><api:request href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/381"/><api:result><api:object category="publication" id="381" last-affected-when="2024-03-15T05:14:05.4+00:00" last-modified-when="2024-03-15T05:14:05.4+00:00" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/381" created-when="2010-05-17T13:46:18.657+01:00" type-id="5" type-display-name="Journal article" type="journal-article"><api:privacy-level>Public</api:privacy-level><api:privacy-level-locked>false</api:privacy-level-locked><api:ever-approved>true</api:ever-approved><api:reporting-date-1>1999-06-11</api:reporting-date-1><api:allow-type-switching>true</api:allow-type-switching><api:records><api:record format="native" id="4199805" source-id="28" source-name="eprints" source-display-name="White Rose Research Online" id-at-source="83688" last-modified-when="2022-12-28T17:50:20.37+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>It has been suggested in a number of studies that susceptibility to adult Hodgkin's disease (HD) is influenced by the HLA class II region, and specifically by alleles at the HLA-DPB1 locus. Since HD is diagnostically complex, it is not clear whether different HLA-DPB1 alleles confer susceptibility to different HD subtypes. To clarify this we have extended a previous study to type DPB1 alleles in 147 adult HD patients from a single centre. We have analysed patients with nodular sclerosing (NS), mixed cellularity (MC) or lymphocyte predominant (LP) HD, and gender in relation to HLA-DPB1 type, in comparison with 183 adult controls. The results confirmed previously reported associations of DPB1*0301 with HD susceptibility (relative risk (RR) = 1.42; 95% confidence interval (CI) 0.86-2.36) and DPB1*0201 with resistance to HD (RR = 0.49; CI 0.27-0.90). However, analysis by HD subtype and gender showed that *0301-associated susceptibility was confined to females with HD (RR = 2.46; CI 1.02-5.92), and *0201-associated resistance to females with NS-HD (RR = 0.28; CI 0.10-0.79). Susceptibility to NS-HD was also associated in females with *1001 (RR = 11.73; CI 1.32-104.36), and resistance with *1101 (RR = 0.08; CI 0.01-0.65). In contrast, susceptibility to LP-HD was associated in males with *2001 (RR = 32.14; CI 3.17-326.17), and to MC-HD with *3401 (RR = 16.78; CI 2.84-99.17). Comparison of DPB1-encoded polymorphic amino-acid frequencies in patients and controls showed that susceptibility to MC-HD was associated with Leucine at position 35 of DPB1 (RR = 8.85; CI 3.04-25.77), Alanine-55 (RR = 15.17; CI 2.00-115.20) and Valine-84 (RR = 15.94; CI 3.55-71.49). In contrast, Glutamic acid 69 was significantly associated with resistance to MC-HD (RR = 0.14; CI 0.03-0.60). Certain DPB1 alleles and individual DPbeta1 polymorphic amino acid residues may thus affect susceptibility and resistance to specific HD subtypes. This may be through their influence on the binding of peptides derived from an HD-associated infectious agent, and the consequent effect on immune responses to the agent.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Taylor</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gokhale</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Crowther</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Harris</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ryder</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ayres</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Radford</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>http://www.ncbi.nlm.nih.gov/pubmed/10424743</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690536</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690536"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690536"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Adolescent</api:keyword><api:keyword>Adult</api:keyword><api:keyword>Alleles</api:keyword><api:keyword>Disease Susceptibility</api:keyword><api:keyword>Female</api:keyword><api:keyword>HLA-DP Antigens</api:keyword><api:keyword>HLA-DP beta-Chains</api:keyword><api:keyword>Hodgkin Disease</api:keyword><api:keyword>Humans</api:keyword><api:keyword>Male</api:keyword><api:keyword>Middle Aged</api:keyword><api:keyword>Phenotype</api:keyword></api:keywords></api:field><api:field name="notes" type="text" display-name="Other information"><api:text>© 1999 Cancer Research Campaign. Reproduced in accordance with the publisher's self-archiving policy.</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1405</api:begin-page><api:end-page>1411</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="public-url" type="text" display-name="Public URL"><api:text>https://eprints.whiterose.ac.uk/id/eprint/83688</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Nature</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1038/sj.bjc.6690536</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>20</api:day><api:month>2</api:month><api:year>2015</api:year></api:date></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>23</api:day><api:month>2</api:month><api:year>2015</api:year></api:date></api:field><api:field name="repository-status" type="text" display-name="Availability"><api:text>Public</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes.</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field><api:files><api:file proprietary-id="https://eprints.whiterose.ac.uk/id/file/537506"><api:filename>Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes..pdf</api:filename><api:file-url>https://eprints.whiterose.ac.uk/83688/1/Further investigation of the role of HLA-DPB1 in adult Hodgkin%27s disease %28HD%29 suggests an influence on susceptibility to different HD subtypes..pdf</api:file-url><api:extension>pdf</api:extension><api:file-size>87602</api:file-size><api:mime-type>application/pdf</api:mime-type><api:checksum algorithm="md5">CAFD6CAE9B5AC03FA72EA69378DC929F</api:checksum><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="1488781" source-id="13" source-name="crossref" source-display-name="Crossref" id-at-source="10.1038/sj.bjc.6690536" last-modified-when="2023-05-20T00:44:15.01+01:00"><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Taylor</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gokhale</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Crowther</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Harris</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ryder</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ayres</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Radford</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690536</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690536"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690536"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="language" type="text" display-name="Language"><api:text>en</api:text></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>11</api:day><api:month>6</api:month><api:year>1999</api:year></api:date></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1405</api:begin-page><api:end-page>1411</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Science and Business Media LLC</api:text></api:field><api:field name="publisher-url" type="text" display-name="Link 2"><api:text>http://dx.doi.org/10.1038/sj.bjc.6690536</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>18</api:day><api:month>5</api:month><api:year>2023</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Further investigation of the role of HLA-DPB1 in adult Hodgkin’s disease (HD) suggests an influence on susceptibility to different HD subtypes</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record><api:record format="native" id="94727" source-id="7" source-name="scopus" source-display-name="Scopus" id-at-source="2-s2.0-0033029820" last-modified-when="2023-08-01T22:04:38.153+01:00"><api:citation-count>35</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>It has been suggested in a number of studies that susceptibility to adult Hodgkin's disease (HD) is influenced by the HLA class II region, and specifically by alleles at the HLA-DPB1 locus. Since HD is diagnostically complex, it is not clear whether different HLA-DPB1 alleles confer susceptibility to different HD subtypes. To clarify this we have extended a previous study to type DPB1 alleles in 147 adult HD patients from a single centre. We have analysed patients with nodular sclerosing (NS), mixed cellularity (MC) or lymphocyte predominant (LP) HD, and gender in relation to HLA-DPB1 type, in comparison with 183 adult controls. The results confirmed previously reported associations of DPB1(*)0301 with HD susceptibility (relative risk (RR)= 1.42; 95% confidence interval (CI) 0.86-2.36) and DPB1(*)0201 with resistance to HD (RR = 0.49; CI 0.27-0.90). However, analysis by HD subtype and gender showed that (*)0301-associated susceptibility was confined to females with HD (RR = 2.46; CI 1.02-5.92), and (*)0201-associated resistance to females with NS-HD (RR = 0.28; CI 0.10-0.79). Susceptibility to NS-HD was also associated in females with (*)1001 (RR = 11.73; CI 1.32-104.36), and resistance with (*)1101 (RR = 0.08; CI 0.01-0.65). In contrast, susceptibility to LP-HD was associated in males with (*)2001 (RR = 32.14; CI 3.17-326.17), and to MC-HD with (*)3401 (RR =16.78; CI 2.84-99.17). Comparison of DPB1-encoded polymorphic amino-acid frequencies in patients and controls showed that susceptibility to MC-HD was associated with Leucine at position 35 of DPB1 (RR = 8.85; CI 3.04-25.77), Alanine-55 (RR = 15.17; CI 2.00-115.20) and Valine-84 (RR = 15.94; CI 3.55-71.49). In contrast, Glutamic acid 69 was significantly associated with resistance to MC-HD (RR = 0.14; CI 0.03-0.60). Certain DPB1 alleles and individual DPβ1 polymorphic amino acid residues may thus affect susceptibility and resistance to specific HD subtypes. This may be through their influence on the binding of peptides derived from an HD-associated infectious agent, and the consequent effect on immune responses to the agent.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Taylor</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">St Mary's Hospital</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35453110900</api:identifier></api:identifiers></api:person><api:person><api:last-name>Gokhale</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">St Mary's Hospital</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7006172700</api:identifier></api:identifiers></api:person><api:person><api:last-name>Crowther</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie NHS Foundation Trust</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">16136499900</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie NHS Foundation Trust</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nottingham City Hospital</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005024157</api:identifier></api:identifiers></api:person><api:person><api:last-name>Harris</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie NHS Foundation Trust</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">35378141000</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ryder</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie NHS Foundation Trust</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7004330354</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ayres</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">St Mary's Hospital</api:line><api:line type="city">London</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7005230019</api:identifier></api:identifiers></api:person><api:person><api:last-name>Radford</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie NHS Foundation Trust</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="scopus-author-id">7102677703</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690536</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690536"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690536"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10424743</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1405</api:begin-page><api:end-page>1411</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:day>14</api:day><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record><api:record format="native" id="381" source-id="2" source-name="pubmed" source-display-name="PubMed" id-at-source="10424743" last-modified-when="2022-11-22T20:56:43.4+00:00"><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>It has been suggested in a number of studies that susceptibility to adult Hodgkin's disease (HD) is influenced by the HLA class II region, and specifically by alleles at the HLA-DPB1 locus. Since HD is diagnostically complex, it is not clear whether different HLA-DPB1 alleles confer susceptibility to different HD subtypes. To clarify this we have extended a previous study to type DPB1 alleles in 147 adult HD patients from a single centre. We have analysed patients with nodular sclerosing (NS), mixed cellularity (MC) or lymphocyte predominant (LP) HD, and gender in relation to HLA-DPB1 type, in comparison with 183 adult controls. The results confirmed previously reported associations of DPB1*0301 with HD susceptibility (relative risk (RR) = 1.42; 95% confidence interval (CI) 0.86-2.36) and DPB1*0201 with resistance to HD (RR = 0.49; CI 0.27-0.90). However, analysis by HD subtype and gender showed that *0301-associated susceptibility was confined to females with HD (RR = 2.46; CI 1.02-5.92), and *0201-associated resistance to females with NS-HD (RR = 0.28; CI 0.10-0.79). Susceptibility to NS-HD was also associated in females with *1001 (RR = 11.73; CI 1.32-104.36), and resistance with *1101 (RR = 0.08; CI 0.01-0.65). In contrast, susceptibility to LP-HD was associated in males with *2001 (RR = 32.14; CI 3.17-326.17), and to MC-HD with *3401 (RR = 16.78; CI 2.84-99.17). Comparison of DPB1-encoded polymorphic amino-acid frequencies in patients and controls showed that susceptibility to MC-HD was associated with Leucine at position 35 of DPB1 (RR = 8.85; CI 3.04-25.77), Alanine-55 (RR = 15.17; CI 2.00-115.20) and Valine-84 (RR = 15.94; CI 3.55-71.49). In contrast, Glutamic acid 69 was significantly associated with resistance to MC-HD (RR = 0.14; CI 0.03-0.60). Certain DPB1 alleles and individual DPbeta1 polymorphic amino acid residues may thus affect susceptibility and resistance to specific HD subtypes. This may be through their influence on the binding of peptides derived from an HD-associated infectious agent, and the consequent effect on immune responses to the agent.</api:text></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Taylor</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="full">Immunogenetics Laboratory, Department of Medical Genetics, St Mary's Hospital, Manchester, UK.</api:line></api:address></api:addresses></api:person><api:person><api:last-name>Gokhale</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Crowther</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Harris</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ryder</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ayres</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Radford</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.ncbi.nlm.nih.gov/pubmed/10424743</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690536</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690536"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690536"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pmc">PMC2363076</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>Br J Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Alleles</api:keyword><api:keyword scheme="mesh">Disease Susceptibility</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">HLA-DP Antigens</api:keyword><api:keyword scheme="mesh">HLA-DP beta-Chains</api:keyword><api:keyword scheme="mesh">Hodgkin Disease</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Phenotype</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="location" type="text" display-name="Country"><api:text>England</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1405</api:begin-page><api:end-page>1411</api:end-page></api:pagination></api:field><api:field name="pii" type="text" display-name="PII"><api:text>6690536</api:text></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="record-made-public-at-source-date" type="date" display-name="Record made publicly available"><api:date><api:day>5</api:day><api:month>8</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Journal Article</api:item><api:item>Research Support, Non-U.S. Gov't</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record><api:record format="native" id="881816" source-id="18" source-name="epmc" source-display-name="Europe PubMed Central" id-at-source="MED:10424743" last-modified-when="2023-11-21T18:54:40.443+00:00"><api:citation-count>19</api:citation-count><api:native><api:field name="abstract" type="text" display-name="Abstract"><api:text>It has been suggested in a number of studies that susceptibility to adult Hodgkin's disease (HD) is influenced by the HLA class II region, and specifically by alleles at the HLA-DPB1 locus. Since HD is diagnostically complex, it is not clear whether different HLA-DPB1 alleles confer susceptibility to different HD subtypes. To clarify this we have extended a previous study to type DPB1 alleles in 147 adult HD patients from a single centre. We have analysed patients with nodular sclerosing (NS), mixed cellularity (MC) or lymphocyte predominant (LP) HD, and gender in relation to HLA-DPB1 type, in comparison with 183 adult controls. The results confirmed previously reported associations of DPB1*0301 with HD susceptibility (relative risk (RR) = 1.42; 95% confidence interval (CI) 0.86-2.36) and DPB1*0201 with resistance to HD (RR = 0.49; CI 0.27-0.90). However, analysis by HD subtype and gender showed that *0301-associated susceptibility was confined to females with HD (RR = 2.46; CI 1.02-5.92), and *0201-associated resistance to females with NS-HD (RR = 0.28; CI 0.10-0.79). Susceptibility to NS-HD was also associated in females with *1001 (RR = 11.73; CI 1.32-104.36), and resistance with *1101 (RR = 0.08; CI 0.01-0.65). In contrast, susceptibility to LP-HD was associated in males with *2001 (RR = 32.14; CI 3.17-326.17), and to MC-HD with *3401 (RR = 16.78; CI 2.84-99.17). Comparison of DPB1-encoded polymorphic amino-acid frequencies in patients and controls showed that susceptibility to MC-HD was associated with Leucine at position 35 of DPB1 (RR = 8.85; CI 3.04-25.77), Alanine-55 (RR = 15.17; CI 2.00-115.20) and Valine-84 (RR = 15.94; CI 3.55-71.49). In contrast, Glutamic acid 69 was significantly associated with resistance to MC-HD (RR = 0.14; CI 0.03-0.60). Certain DPB1 alleles and individual DPbeta1 polymorphic amino acid residues may thus affect susceptibility and resistance to specific HD subtypes. This may be through their influence on the binding of peptides derived from an HD-associated infectious agent, and the consequent effect on immune responses to the agent.</api:text></api:field><api:field name="addresses" type="address-list" display-name="Addresses"><api:addresses><api:address iso-country-code="GB"><api:line type="full">Immunogenetics Laboratory, Department of Medical Genetics, St Mary's Hospital, Manchester, UK.</api:line></api:address></api:addresses></api:field><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Taylor</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gokhale</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Crowther</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0002-1118-0831</api:identifier></api:identifiers></api:person><api:person><api:last-name>Harris</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ryder</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ayres</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Radford</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:identifiers><api:identifier scheme="orcid">0000-0001-7898-2786</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690536</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690536"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690536"/></api:links></api:field><api:field name="eissn" type="text" display-name="eISSN"><api:text>1532-1827</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10424743</api:identifier><api:identifier scheme="pmc">PMC2363076</api:identifier></api:identifiers></api:field><api:field name="is-open-access" type="boolean" display-name="Open access"><api:boolean>true</api:boolean></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British journal of cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Hodgkin Disease</api:keyword><api:keyword scheme="mesh">Disease Susceptibility</api:keyword><api:keyword scheme="mesh">HLA-DP Antigens</api:keyword><api:keyword scheme="mesh">Phenotype</api:keyword><api:keyword scheme="mesh">Alleles</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">HLA-DP beta-Chains</api:keyword></api:keywords></api:field><api:field name="language" type="text" display-name="Language"><api:text>eng</api:text></api:field><api:field name="medium" type="text" display-name="Medium"><api:text>Print</api:text></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Open Access</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1405</api:begin-page><api:end-page>1411</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="publisher-licence" type="text" display-name="Publisher licence"><api:text>CC BY</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>29</api:day><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="title" type="text" display-name="Title"><api:text>Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes.</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Research Support, Non-U.S. Gov't</api:item><api:item>research-article</api:item><api:item>Journal Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field><api:files><api:file proprietary-id="https://www.nature.com/articles/6690536.pdf"><api:file-url>https://www.nature.com/articles/6690536.pdf</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file><api:file proprietary-id="https://europepmc.org/articles/PMC2363076?pdf=render"><api:file-url>https://europepmc.org/articles/PMC2363076?pdf=render</api:file-url><api:extension>pdf</api:extension><api:is-open-access>true</api:is-open-access><api:file-version>Published version</api:file-version></api:file></api:files></api:native></api:record><api:record format="native" id="2708441" source-id="10" source-name="dimensions" source-display-name="Dimensions" id-at-source="pub.1023897476" last-modified-when="2024-01-20T19:18:50.183+00:00"><api:citation-count>39</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Taylor</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">St Mary's Hospital</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01072615212.76</api:identifier></api:identifiers></api:person><api:person><api:last-name>Gokhale</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">St Mary's Hospital</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01040764044.31</api:identifier></api:identifiers></api:person><api:person><api:last-name>Crowther</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie Hospital</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01213610220.66</api:identifier></api:identifiers></api:person><api:person><api:links><api:link type="elements/user" id="365" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/users/365"/></api:links><api:last-name>Woll</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie Hospital</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address><api:address iso-country-code="GB"><api:line type="organisation">Nottingham City Hospital</api:line><api:line type="city">Nottingham</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.0672175303.65</api:identifier></api:identifiers></api:person><api:person><api:last-name>Harris</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie Hospital</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.012402751432.71</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ryder</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie Hospital</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01055673441.93</api:identifier></api:identifiers></api:person><api:person><api:last-name>Ayres</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">St Mary's Hospital</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01227277536.09</api:identifier></api:identifiers></api:person><api:person><api:last-name>Radford</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names><api:addresses><api:address iso-country-code="GB"><api:line type="organisation">The Christie Hospital</api:line><api:line type="city">Manchester</api:line><api:line type="country">United Kingdom</api:line></api:address></api:addresses><api:identifiers><api:identifier scheme="dimensions-researcher-id">ur.01246256374.21</api:identifier></api:identifiers></api:person></api:people></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690536</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690536"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690536"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="pubmed">10424743</api:identifier><api:identifier scheme="pmc">PMC2363076</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>British Journal of Cancer</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword scheme="for-2020">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020">3201 Cardiovascular Medicine and Haematology</api:keyword><api:keyword scheme="sdg">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh">Adolescent</api:keyword><api:keyword scheme="mesh">Adult</api:keyword><api:keyword scheme="mesh">Alleles</api:keyword><api:keyword scheme="mesh">Disease Susceptibility</api:keyword><api:keyword scheme="mesh">Female</api:keyword><api:keyword scheme="mesh">HLA-DP Antigens</api:keyword><api:keyword scheme="mesh">HLA-DP beta-Chains</api:keyword><api:keyword scheme="mesh">Hodgkin Disease</api:keyword><api:keyword scheme="mesh">Humans</api:keyword><api:keyword scheme="mesh">Male</api:keyword><api:keyword scheme="mesh">Middle Aged</api:keyword><api:keyword scheme="mesh">Phenotype</api:keyword></api:keywords></api:field><api:field name="online-publication-date" type="date" display-name="Online publication date"><api:date><api:day>11</api:day><api:month>6</api:month><api:year>1999</api:year></api:date></api:field><api:field name="open-access-status" type="text" display-name="Open access status"><api:text>Hybrid OA</api:text></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1405</api:begin-page><api:end-page>1411</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:month>7</api:month><api:year>1999</api:year></api:date></api:field><api:field name="publisher" type="text" display-name="Publisher"><api:text>Springer Nature</api:text></api:field><api:field name="record-created-at-source-date" type="date" display-name="Record created at source"><api:date><api:day>31</api:day><api:month>8</api:month><api:year>2017</api:year></api:date></api:field><api:field name="relative-citation-ratio" type="decimal" display-name="Relative citation ratio"><api:decimal>0.73</api:decimal></api:field><api:field name="title" type="text" display-name="Title"><api:text>Further investigation of the role of HLA-DPB1 in adult Hodgkin’s disease (HD) suggests an influence on susceptibility to different HD subtypes</api:text></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record><api:record format="native" id="3245252" source-id="11" source-name="wos-lite" source-display-name="Web of Science (Lite)" id-at-source="WOS:000081230000015" last-modified-when="2024-03-15T05:14:05.403+00:00"><api:citation-count>35</api:citation-count><api:native><api:field name="authors" type="person-list" display-name="Authors"><api:people><api:person><api:last-name>Taylor</api:last-name><api:initials>GM</api:initials><api:first-names>GM</api:first-names><api:separate-first-names><api:first-name>G</api:first-name><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Gokhale</api:last-name><api:initials>DA</api:initials><api:first-names>DA</api:first-names><api:separate-first-names><api:first-name>D</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Crowther</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Wolf</api:last-name><api:initials>PJ</api:initials><api:first-names>PJ</api:first-names><api:separate-first-names><api:first-name>P</api:first-name><api:first-name>J</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Harris</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ryder</api:last-name><api:initials>D</api:initials><api:first-names>D</api:first-names><api:separate-first-names><api:first-name>D</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Ayres</api:last-name><api:initials>M</api:initials><api:first-names>M</api:first-names><api:separate-first-names><api:first-name>M</api:first-name></api:separate-first-names></api:person><api:person><api:last-name>Radford</api:last-name><api:initials>JA</api:initials><api:first-names>JA</api:first-names><api:separate-first-names><api:first-name>J</api:first-name><api:first-name>A</api:first-name></api:separate-first-names></api:person></api:people></api:field><api:field name="author-url" type="text" display-name="Link 1"><api:text>https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=sheffield_elements_live&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000081230000015&amp;DestLinkType=FullRecord&amp;DestApp=WOS_CPL</api:text></api:field><api:field name="doi" type="text" display-name="DOI"><api:text>10.1038/sj.bjc.6690536</api:text><api:links><api:link type="doi" href="http://doi.org/10.1038/sj.bjc.6690536"/><api:link type="altmetric" href="http://www.altmetric.com/details.php?doi=10.1038/sj.bjc.6690536"/></api:links></api:field><api:field name="external-identifiers" type="identifier-list" display-name="External identifiers"><api:identifiers><api:identifier scheme="isidoc">212RL</api:identifier><api:identifier scheme="pubmed">10424743</api:identifier></api:identifiers></api:field><api:field name="issn" type="text" display-name="ISSN"><api:text>0007-0920</api:text><api:links><api:link type="elements/journal" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662"/></api:links></api:field><api:field name="issue" type="text" display-name="Issue"><api:text>9</api:text></api:field><api:field name="journal" type="text" display-name="Journal"><api:text>BRITISH JOURNAL OF CANCER</api:text></api:field><api:field name="keywords" type="keyword-list" display-name="Keywords"><api:keywords><api:keyword>Hodgkin's disease</api:keyword><api:keyword>HLA-DPB1</api:keyword><api:keyword>HVR</api:keyword><api:keyword>susceptibility</api:keyword><api:keyword>resistance</api:keyword><api:keyword>polymorphic amino acid</api:keyword></api:keywords></api:field><api:field name="pagination" type="pagination" display-name="Pagination"><api:pagination><api:begin-page>1405</api:begin-page><api:end-page>1411</api:end-page></api:pagination></api:field><api:field name="publication-date" type="date" display-name="Publication date"><api:date><api:year>1999</api:year></api:date></api:field><api:field name="publication-status" type="text" display-name="Status"><api:text>Published</api:text></api:field><api:field name="title" type="text" display-name="Title"><api:text>Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes</api:text></api:field><api:field name="types" type="list" display-name="Sub types"><api:items><api:item>Article</api:item></api:items></api:field><api:field name="volume" type="text" display-name="Volume"><api:text>80</api:text></api:field></api:native></api:record></api:records><api:fields/><api:all-labels type="keyword-list"><api:keywords><api:keyword origin="record-data" source="eprints">Adolescent</api:keyword><api:keyword origin="record-data" source="eprints">Adult</api:keyword><api:keyword origin="record-data" source="eprints">Alleles</api:keyword><api:keyword origin="record-data" source="eprints">Disease Susceptibility</api:keyword><api:keyword origin="record-data" source="eprints">Female</api:keyword><api:keyword origin="record-data" source="eprints">HLA-DP Antigens</api:keyword><api:keyword origin="record-data" source="eprints">HLA-DP beta-Chains</api:keyword><api:keyword origin="record-data" source="eprints">Hodgkin Disease</api:keyword><api:keyword origin="record-data" source="eprints">Humans</api:keyword><api:keyword origin="record-data" source="eprints">Male</api:keyword><api:keyword origin="record-data" source="eprints">Middle Aged</api:keyword><api:keyword origin="record-data" source="eprints">Phenotype</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Alleles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Disease Susceptibility</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">HLA-DP Antigens</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">HLA-DP beta-Chains</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Hodgkin Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="pubmed">Phenotype</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Hodgkin Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Disease Susceptibility</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">HLA-DP Antigens</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Phenotype</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Alleles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="epmc">HLA-DP beta-Chains</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">32 Biomedical and Clinical Sciences</api:keyword><api:keyword scheme="for-2020" origin="record-data" source="dimensions">3201 Cardiovascular Medicine and Haematology</api:keyword><api:keyword scheme="sdg" origin="record-data" source="dimensions">3 Good Health and Well Being</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adolescent</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Adult</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Alleles</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Disease Susceptibility</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Female</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">HLA-DP Antigens</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">HLA-DP beta-Chains</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Hodgkin Disease</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Humans</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Male</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Middle Aged</api:keyword><api:keyword scheme="mesh" origin="record-data" source="dimensions">Phenotype</api:keyword><api:keyword origin="record-data" source="wos-lite">Hodgkin's disease</api:keyword><api:keyword origin="record-data" source="wos-lite">HLA-DPB1</api:keyword><api:keyword origin="record-data" source="wos-lite">HVR</api:keyword><api:keyword origin="record-data" source="wos-lite">susceptibility</api:keyword><api:keyword origin="record-data" source="wos-lite">resistance</api:keyword><api:keyword origin="record-data" source="wos-lite">polymorphic amino acid</api:keyword><api:keyword scheme="for" origin="issn-inferred">1112 Oncology and Carcinogenesis</api:keyword><api:keyword scheme="for" origin="issn-inferred">1117 Public Health and Health Services</api:keyword><api:keyword scheme="science-metrix" origin="issn-inferred">Oncology &amp; Carcinogenesis</api:keyword><api:keyword scheme="for-2020" origin="issn-inferred">3211 Oncology and carcinogenesis</api:keyword></api:keywords></api:all-labels><api:journal issn="0007-0920" href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/journals/973662" title="British Journal of Cancer"><api:records><api:record source-name="summary"><api:title>British Journal of Cancer</api:title></api:record></api:records></api:journal><api:relationships href="https://mypublications.shef.ac.uk:8091/secure-api/v6.13/publications/381/relationships"/></api:object></api:result></api:response>